欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2024, Vol. 29 ›› Issue (6): 690-699.doi: 10.12092/j.issn.1009-2501.2024.06.011

• 综述与讲座 • 上一篇    下一篇

单细胞多组学测序技术在缺血性脑卒中研究中的应用

孟倩1,2,王依玟2,崔娜2,白敏2,杨乐3,丁一2   

  1. 1西北大学生命科学学院,西安  710069,陕西;2空军军医大学西京医院药剂科,西安  710032,陕西;3空军军医大学唐都医院药剂科,西安  710038,陕西

  • 收稿日期:2023-09-07 修回日期:2024-01-17 出版日期:2024-06-26 发布日期:2024-05-20
  • 通讯作者: 丁一,男,副主任药师,博士研究生导师,研究方向:中药药理学。 E-mail: dingyi.007@163.com
  • 作者简介:孟倩,女,硕士研究生,研究方向:神经生物学。 E-mail: qianmeng1233@163.com
  • 基金资助:
    国家自然科学基金(82274313)

Application of single-cell multi-omics sequencing technology in the study of ischemic stroke

MENG Qian1,2, WANG Yiwen2, CUI Na2, BAI Min2, YANG Le3, DING Yi2   

  1. 1College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China; 2Department of Pharmacy, Xijing Hospital, Air Force Medical University, Xi'an 710032,  Shaanxi, China; 3Department of Pharmacy, Tangdu Hospital, Air Force Medical University, Xi'an 710038,  Shaanxi, China
  • Received:2023-09-07 Revised:2024-01-17 Online:2024-06-26 Published:2024-05-20

摘要:

缺血性脑卒中是一种致残率和死亡率较高的急性脑血管疾病,是中国最常见的死亡原因。尽管已有多年研究,但是仍没有脑卒中生物标志物,其分子机制在很大程度上仍不清楚。近十年来,单细胞测序技术作为高速发展起来的一门新兴技术,能够在单个细胞水平上对基因组、转录组、表观遗传组、蛋白组等多组学联合进行高通量测序,为发现生物标志物及解析病理机制提供了新途径。本文详细介绍了单细胞多组学测序技术的进展及其在发现缺血性脑卒中的生物标志物及病理机制等方面的应用,以期为缺血性脑卒中的精准医疗提供有价值的参考。

关键词: 缺血性脑卒中, 单细胞测序, 单细胞多组学, 生物标志物, 精准医疗

Abstract:

Ischemic stroke is an acute cerebrovascular disease with high disability and mortality, is the most common cause of death in China. Despite years of research, there are still no biomarkers for stroke, and the molecular mechanisms remain largely unknown. In the past decade, single-cell sequencing technology, as a rapidly developing emerging technology, can conduct high-throughput sequencing of multiple omics including genome, transcriptome, epigenome and proteome at the level of a single cell, providing a new way to discover biomarkers and analyze pathological mechanisms. In this paper, the progress of single-cell multi-omics sequencing technology and its application in the discovery of biomarkers, pathological mechanisms and drug development of ischemic stroke are introduced in detail, in order to provide valuable reference for precision medicine of ischemic stroke.

Key words: ischemic stroke, single-cell sequencing, single-cell multi-omics, biomarkers, precision medicine

中图分类号: